OTC Watch

All stocks / ATXI

AVENUE THERAPEUTICS, INC. ATXI

Avenue Therapeutics (ATXI): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated float OTCIDFlorida, USA
Live quote on OTC Markets

Market listing

Full name
AVENUE THERAPEUTICS INC
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 16
Source: Stockwatch, 2026-11-17

News headlines

Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
2026-02-23 08:00 ยท News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$1,404,000
Net loss
($2,909,000)
What it means

It spends more than it earns

Under strain

Customers paid it $1.4 million in the year. It lost $2.9 million. For every $1 that came in, about $3.07 went out.

The report says
Cash and cash equivalents
$2,855,000
Net cash used in operating activities
($1,833,000)
What it means

It has cash for a while

Steady

It had $2.9 million in the bank and used about $152,750 a month. At that pace the money lasts about 19 months unless it borrows or sells more shares.

The report says
Total assets
$2,931,000
Total liabilities
$1,099,000
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $2.9 million. Its debts and unpaid bills add up to $1.1 million. That is about $0.37 owed for every $1 owned.

What this adds up to

1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-04

Estimated float about 2,855,234 shares as of 2026-11-04: 3,294,967 outstanding minus 439,733 held by 1 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-12-31
3.2M
2026-03-25
3.3M
2026-03-31
3.3M
2026-05-06
3.3M
2026-06-30
3.3M
2026-08-04
3.3M
2026-09-30
3.3M
2026-11-04
3.3M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-06 10-QFORM 10-Q
2026-08-07 10-QFORM 10-Q
2026-05-08 10-QFORM 10-Q
2026-03-30 10-KFORM 10-K
2026-02-23 8-KFORM 8-K
2026-02-17 SCHEDULE 13G/A
2026-01-06 4
2026-01-06 SCHEDULE 13D/A
2025-12-31 8-KFORM 8-K
2025-12-16 EFFECT
2025-12-15 RWRW
2025-12-15 POS AMPOS AM

Common questions about ATXI

Does ATXI file reports with the SEC?

Yes. Avenue Therapeutics files with the SEC under company number 0001644963. The most recent filing we hold is a 10-Q dated 2026-11-06.

Source record

How many ATXI shares are outstanding?

3,294,967 shares as of 2026-11-04, as reported to the SEC.

Source record

Has ATXI filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is Avenue Therapeutics making money?

Customers paid it $1.4 million in the year. It lost $2.9 million. For every $1 that came in, about $3.07 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record